Science & Research
XBiotech's Vilamakitug Clears FDA IND Review for Phase II AxSpA Trial
The V-SPINE study opens U.S. enrollment for a condition with significant unmet need, signaling continued biotech intere…
Science & Research 42 stories
Science & Research
Grifols Launches FDA-Approved Fibrinogen Concentrate FESILTY in U.S.
The plasma-derived concentrate targets a rare bleeding disorder affecting both pediatric and adult patients — a niche b…
Science & Research
Pharvaris HAE Drug Data Presented at EAACI 2026
The late-stage biopharmaceutical asset targets bradykinin-mediated angioedema — a rare-disease space with limited oral …
Science & Research
Orelabrutinib Data at EHA 2026: What Nutraceutical Formulators Should Know
As precision oncology expands BTK-inhibitor research, ingredient developers tracking immune-pathway mechanisms are watc…
Science & Research
Ascentage Pharma Posts 17 Clinical Updates at EHA2026
Data from Stockholm congress covers two China-approved oncology assets with implications for global development pipelin…
Science & Research
Setmelanotide Phase 2 Interim Data Due for Prader-Willi Syndrome
The MC4R-pathway agonist is under scrutiny as a potential model for appetite-regulating therapeutics at the rare-diseas…
Science & Research
Disc Medicine Reports Durable Anemia Response in MF Trial
Bitopertin also posts sustained PPIX reductions and improved light tolerance in EPP extension trial, broadening Disc Me…
Science & Research
Remibrutinib Phase III Data Signal BTK Inhibition Path for Chronic Urticaria
A supplemental NDA has been filed with the FDA for the symptomatic dermographism subtype — a regulatory move that could…
Science & Research
GraftAssure Assay Claims Superiority in Transplant Rejection Screening
Peer-reviewed data published in a leading transplant journal positions the diagnostic tool as a new clinical benchmark …
Science & Research
TransCon PTH Five-Year Data Show Sustained PTH Replacement in Hypoparathyroidism
Long-term clinical follow-up bolsters the case for physiologic hormone replacement as a therapeutic model with implicat…
Science & Research
VCN-01 Oncolytic Virus Shows Overall Survival Signal in Phase I Trial
Phase I data published in Clinical Cancer Research positions VCN-01 as a potential immuno-oncology primer — but the fin…
Science & Research
Parexel to Lead Eight Sessions on AI, RWE at DIA 2026
Sessions touch on AI-driven trial design and real-world evidence collection — tools with growing relevance for nutraceu…